A Universal Electronic Health Record-based IMPROVE DD VTE Risk Assessment Model for the Prevention of Thromboembolism in Hospitalized Medically Ill Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Alex Spyropoulos, MD
Northwell Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- North Shore University Hospital
Manhasset, New York, United States
- the Institute for Health Innovations and Outcomes Research
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Staten Island University Hospital
Staten Island, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2020
- Primary completion
- 21 Jan 2022
- Completion
- 21 Jan 2022
- Last update posted
- 2 Aug 2022
- Registered enrollment
- 10,699
- Registry id
- NCT04768036
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.